At a glance
ClinicalIndex Comparison Record- ✓Histologically confirmed breast cancer
- ✓Stage I or II disease (T1-T2, N0, M0/MX)
- ✓Medially or centrally located lesion
- ✓No clinically positive axillary nodes
- ✕Chest wall invasion (T3 disease)
- ✕Multicentric disease
- ✕Prior thoracic or cardiac surgery
- ✕Prior ipsilateral chest tube placement
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Thoracoscopic Internal Mammary Sentinel Node Biopsy
In Brief
A clinical study evaluating Isosulfan blue, Axillary Lymph Node Dissection, and 4 other interventions for Breast Cancer. Completed, enrolled 39 participants across 1 site.
Detailed Summary
RATIONALE: Diagnostic procedures, such as thoracoscopic sentinel lymph node biopsy, may help find breast cancer that has spread to lymph nodes between the breasts. It may also help doctors plan the best treatment. PURPOSE: This clinical trial is studying how well thoracoscopic sentinel lymph node biopsy finds sentinel lymph nodes that are located between the breasts in patients with stage I or stage II breast cancer.
Study Details
Timeline
Interventions
Administered pre-surgery; injection of 2 cc of Isosulfan Blue in four equal aliquots of 0.5 cc as routinely done for the axillary sentinel node procedure.
Axillary Lymph Node Dissection
The surgery will be performed under general anesthesia with a single lumen endo-tracheal tube. The patient will be laid in a semi decubitus position on the opposite side with the ipsilateral arm bent over the head and attached to an arm rest.
Sentinel Lymph Node Biopsy
Performed only if internal mammary sentinel node cannot be retrieved via same incision of lumpectomy/mastectomy.
Two to three hours prior to surgery, a peritumoral injection of filtered Technetium Sulfur Colloid will be performed in four 0.25 mci/2cc aliquots